Video: Serial Entrepreneur Tells Compelling Personal Story about His Entrepreneurial Path

Growing up in East Liverpool, OH, Mike Triplett, president and chief executive officer, Myonexus, a spinout of Nationwide Children’s Hospital acquired by Sarepta Therapeutics earlier this year in $165MM exit, lived the socio and economic devastation that occurred when the steel industry collapsed.

This fascinating Founder’s Story begins with a question to Mike: Why are you doing what you are doing?

“In my elementary school experience, I was surrounded by friends and kids that would come to school crying. The bank was taking the house. The cars were being repossessed. This factory was closing down. This store was closing down. I’m a first-generation college graduate, so I lived it from my father being president of the union, going on strike and ultimately the factory shutting down when I was probably 12 or 13. That experience led me onto a journey of trying to understand how that happened.”

Mike’s journey became a quest. From a degree in engineering, to post-graduate work, to a career path that includes success in large private companies, research organizations, and on into the startup world, he has lived and driven innovation throughout his entire career.

About the Speaker: Michael Triplett, Ph.D.

Dr. Michael Triplett is co-founder and partner at 1787 Bio, LLC, a diversified gene and cell therapy company headquartered in Columbus, OH, and president of Carmen Partners LLC, a life science ventures, commercialization, and innovation consultancy.

Dr. Triplett co-founded and served as president and CEO of Myonexus Therapeutics. Prior to co-founding Myonexus Therapeutics, Dr. Triplett served as chief executive officer of N8 Medical, a clinical stage combination device company with breakthrough designation for its lead antimicrobial endotracheal tube product.

Dr. Triplett is currently leading the InnovateOhio Life Sciences Working Group for Ohio Lt. Governor Jon Husted with the mission to propose a life sciences economic development strategy for the State of Ohio.

Comments are closed.